Aptamer Sciences Inc

A291650

KR7291650000

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
2,750 ^KRW	+3.19%		+4.56%	-23.72%

Mar. 26	Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	CI
2022	Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	CI

Aptamer Sciences Inc(KOSDAQ:A291650) dropped from S&P Global BMI Index

September 19, 2022 at 12:00 am EDT

Latest news about Aptamer Sciences Inc

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201	Mar. 25	CI
Aptamer Sciences Inc announced that it has received KRW 16.5 billion in funding from a group of investors	22-10-05	CI
Aptamer Sciences Inc announced that it expects to receive KRW 16.5 billion in funding from a group of investors	22-10-03	CI
Aptamer Sciences Inc(KOSDAQ:A291650) dropped from S&P Global BMI Index	22-09-19	CI
Aptamer Sciences Inc.(KOSDAQ:A291650) added to S&P Global BMI Index	21-03-22	CI
Aptamer Sciences Inc. has completed an IPO in the amount of KRW 32.5 billion.	20-09-11	CI
Aptamer Sciences Inc. has filed an IPO.	20-05-25	CI
Aptamer Sciences Inc. has withdrawn its IPO in the amount of KRW 23.4 billion.	20-03-26	CI
Aptamer Sciences Inc. has filed an IPO.	19-11-11	CI
Aptamer Sciences, Inc. announced that it expects to receive $7.3 million in funding	16-06-20	CI

Aptamer Sciences Inc is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as insulin substitutes, insulin sensitizers, and liver cancer drugs. In addition, the Company also produces lung cancer diagnostic kits.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
APTAMER SCIENCES INC	-23.72%	33.93M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B